Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) — Financial Flexibility Index
Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Financial Flexibility Index of 0.22x as of September 2025. Free cash flow of CN¥1.90 Billion (operating CF CN¥1.25 Billion minus capex CN¥652.49 Million) represents 0% of total liabilities (CN¥8.77 Billion). Check 600866 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Starlake Bioscience Co Inc Zhaoqing Guangdong Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Starlake Bioscience Co Inc Zhaoqing Guangdong across 28 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Starlake Bioscience Co Inc Zhaoqing Guan.
Annual Financial Flexibility Index for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Year-by-year free cash flow to debt coverage for Starlake Bioscience Co Inc Zhaoqing Guangdong. Explore Starlake Bioscience Co Inc Zhaoqing Guan cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.38x | CN¥3.33 Billion | CN¥1.29 Billion | CN¥8.79 Billion | ▼ -18.6% |
| 2024 | 0.47x | CN¥3.04 Billion | CN¥2.40 Billion | CN¥6.52 Billion | ▲ +30.4% |
| 2023 | 0.36x | CN¥2.40 Billion | CN¥2.03 Billion | CN¥6.73 Billion | ▲ +53.2% |
| 2022 | 0.23x | CN¥2.11 Billion | CN¥1.66 Billion | CN¥9.07 Billion | ▼ -59.1% |
| 2021 | 0.57x | CN¥397.71 Million | CN¥192.63 Million | CN¥697.74 Million | ▼ -20.5% |
| 2020 | 0.72x | CN¥539.88 Million | CN¥249.99 Million | CN¥752.97 Million | ▲ +15.3% |
| 2019 | 0.62x | CN¥370.58 Million | CN¥213.17 Million | CN¥595.95 Million | ▲ +260.2% |
| 2018 | 0.17x | CN¥84.40 Million | CN¥50.69 Million | CN¥488.94 Million | ▲ +14.4% |
| 2017 | 0.15x | CN¥80.66 Million | CN¥40.05 Million | CN¥534.57 Million | ▲ +18.2% |
| 2016 | 0.13x | CN¥81.43 Million | CN¥41.17 Million | CN¥637.90 Million | ▼ -4.4% |
| 2015 | 0.13x | CN¥106.23 Million | CN¥2.75 Million | CN¥795.88 Million | ▲ +279.4% |
| 2014 | 0.04x | CN¥27.70 Million | CN¥-20.22 Million | CN¥787.37 Million | ▼ -46.2% |
| 2013 | 0.07x | CN¥74.46 Million | CN¥-28.16 Million | CN¥1.14 Billion | ▲ +568.5% |
| 2012 | 0.01x | CN¥16.62 Million | CN¥-276.02 Million | CN¥1.70 Billion | ▼ -98.3% |
| 2011 | 0.57x | CN¥925.40 Million | CN¥65.88 Million | CN¥1.62 Billion | ▼ -20.4% |
| 2010 | 0.72x | CN¥501.03 Million | CN¥104.63 Million | CN¥698.07 Million | ▼ -9.7% |
| 2009 | 0.79x | CN¥379.33 Million | CN¥316.73 Million | CN¥477.36 Million | ▲ +131.9% |
| 2008 | 0.34x | CN¥198.90 Million | CN¥148.93 Million | CN¥580.44 Million | ▲ +32.4% |
| 2007 | 0.26x | CN¥157.18 Million | CN¥82.28 Million | CN¥607.29 Million | ▲ +18.9% |
| 2006 | 0.22x | CN¥112.52 Million | CN¥35.14 Million | CN¥516.89 Million | ▼ -8.6% |
| 2005 | 0.24x | CN¥116.60 Million | CN¥46.83 Million | CN¥489.57 Million | ▼ -60.8% |
| 2004 | 0.61x | CN¥249.81 Million | CN¥29.05 Million | CN¥410.86 Million | ▼ -37.6% |
| 2003 | 0.97x | CN¥259.83 Million | CN¥149.70 Million | CN¥266.82 Million | ▼ -32.2% |
| 2002 | 1.44x | CN¥271.37 Million | CN¥183.18 Million | CN¥188.89 Million | ▲ +155.7% |
| 2001 | 0.56x | CN¥138.17 Million | CN¥60.82 Million | CN¥245.97 Million | ▲ +16.0% |
| 2000 | 0.48x | CN¥160.58 Million | CN¥93.41 Million | CN¥331.53 Million | ▼ -47.4% |
| 1999 | 0.92x | CN¥132.42 Million | CN¥52.97 Million | CN¥143.87 Million | ▼ -17.6% |
| 1998 | 1.12x | CN¥184.87 Million | CN¥71.14 Million | CN¥165.54 Million | — |